Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Damage Dna”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04160208
What this trial is testing

DNA Damage and Subfertility in Males - Impact on ART Outcome

Who this might be right for
Infertility
Regionshospitalet Viborg, Skive 1,350
Testing effectiveness (Phase 2)UnknownNCT05461261
What this trial is testing

The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Hormone Sensitive Metastatic Prostate CancerDNA Damage Repair DeficiencyChemotherapy Effect+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Not applicableStudy completedNCT02922790
What this trial is testing

Feasibility and Smokers' Reactions to DNA Feedback

Who this might be right for
Smoking
Duke University 39
Testing effectiveness (Phase 2)Looking for participantsNCT03740893
What this trial is testing

PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer

Who this might be right for
Breast NeoplasmTriple Negative Breast Cancer (TNBC)HRD
Institute of Cancer Research, United Kingdom 119
Not applicableStudy completedNCT05094960
What this trial is testing

Measurement of Circulating Cell-free DNA (cfDNA) for Diagnosis and Prognosis of Various Diseases and Evaluation of Tissue Damage

Who this might be right for
Correlation of cFDNA During CPB to Laboratories SIRS Parameters and Clinical Outcomes
Soroka University Medical Center 71
Large-scale testing (Phase 3)Looking for participantsNCT06439225
What this trial is testing

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Prostate Cancer
Canadian Cancer Trials Group 236
Early research (Phase 1)Looking for participantsNCT05687110
What this trial is testing

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Who this might be right for
Metastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 43
Post-approval studies (Phase 4)WithdrawnNCT01717846
What this trial is testing

Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis

Who this might be right for
Apoptotic DNA DamageRheumatoid ArthritisT-cell Lymphocytosis
University of California, Los Angeles
Very early researchUnknownNCT04781868
What this trial is testing

Multi-Nutrient Supplement for Radio-Protection

Who this might be right for
Oxidative StressDNA Damage, Radiation InducedRadiation Exposure
McMaster University 30
Early research (Phase 1)Study completedNCT00553189
What this trial is testing

Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas

Who this might be right for
Solid TumorsLymphomas
National Cancer Institute (NCI) 31
Early research (Phase 1)Study completedNCT02630199
What this trial is testing

Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer

Who this might be right for
Refractory Cancer
Samsung Medical Center 65
Not applicableLooking for participantsNCT06999785
What this trial is testing

Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage

Who this might be right for
Hyperbaric OxygenGenotoxicityMalignancy
University Hospital, Angers 60
Not applicableStudy completedNCT07660003
What this trial is testing

8-OHdG and Oxidative Stress in Febrile Seizures

Who this might be right for
Febrile SeizuresOxidative StressOxidative DNA Damage
Kayseri City Hospital 156
Not applicableStudy completedNCT07279896
What this trial is testing

Determination of RNA/DNA Damage Associated With Oxidative Stress in Periodontitis Patients

Who this might be right for
Periodontitis (Stage 3)Smoking
Zehra Hasgül 88
Not applicableStudy completedNCT03284632
What this trial is testing

E-Cigarette - DNA Adducts

Who this might be right for
SmokingCigarette SmokingElectronic Cigarettes
University of Minnesota 217
Testing effectiveness (Phase 2)WithdrawnNCT04655183
What this trial is testing

Study of M4344 in Combination With Niraparib

Who this might be right for
Advanced Solid TumorBreast Cancer
EMD Serono Research & Development Institute, Inc.
Not applicableUnknownNCT03345030
What this trial is testing

The Role of DNA Damage of Granulosa Cell on Oocyte Quality and in Vitro Fertilization Outcome

Who this might be right for
in Vitro Fertilization
Suleyman Demirel University 60
Testing effectiveness (Phase 2)Study completedNCT01994707
What this trial is testing

Remote Ischemic Preconditioning of Human Myocardium

Who this might be right for
Coronary Artery Bypass Graft Triple VesselApoptotic DNA Damage
Medical University of Silesia 134
Not applicableUnknownNCT02231736
What this trial is testing

Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)

Who this might be right for
Type 2 DiabetesCancer
University of Vienna 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT03609216
What this trial is testing

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaStage III Bladder Urothelial Carcinoma
Alliance for Clinical Trials in Oncology 237
Next Page